Eurofins Announces the Inauguration of Its Nantes Laboratory Extension the Largest Single-Site Independent Food Testing Labor...
October 25 2017 - 12:30AM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), a global leader in bioanalytical
testing, inaugurates today an investment of more than EUR 22m in a
brand new 9,500 m2 extension to its state-of-the-art food testing
laboratory in Nantes, France, next to the Company’s first-ever
laboratory.
The newly-completed facility brings total size of the campus to
23,640 m2, making it the largest independent food testing
laboratory site in Europe, including 4,200 m2 of spare capacity
which can be readily used for future growth. The new laboratory
extension was launched in response to the strong growth experienced
and expected by Eurofins. This new fully-modernized state-of-the
art site will help Eurofins better serve the food industry in
France, as well as throughout Europe, and provide a solid basis to
support the Group’s strong acceleration in market share gains.
The new laboratory layout is expected to significantly improve
efficiency, scalability and turn-around times (TAT). Therefore, the
extension project should benefit Eurofins’ customers, who will
continue to receive a high-quality service with lower TAT. The
extension will also increase the breadth of service offerings of
the various Eurofins companies present at this site. These services
include, among others, nutrition analyses, molecular biology, water
testing, asbestos testing, air testing, soil testing, DNA
sequencing, contaminants testing and authenticity testing.
Eurofins Nantes contributes to ca. 45% of Eurofins’ Food Testing
revenues in France, processing nearly 1.5 million samples and
performing 5 million analyses per year. This extension project
reflects Eurofins’ strong commitment to continuously developing and
growing its state-of-the art network of modern world class
laboratories.
Comment from François Vigneau, General Manager for
Eurofins Food Testing South Europe: “Eurofins is proud to have
completed the Nantes extension project as planned. It is remarkable
that in just 30 years, Eurofins Nantes has transitioned from a
small beverages testing specialist to a global leader in food,
pharmaceuticals and environmental testing. This large investment in
laboratory expansion is another demonstration of the Group’s strong
commitment to always offering its clients faster, more sensitive
and more cost-effective advanced testing services.”
For more information, please visit
www.eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysisEurofins
Scientific through its subsidiaries (hereinafter sometimes
“Eurofins” or “the Group”) believes it is the world leader in food,
environment and pharmaceutical products testing and that it is also
one of the global independent market leaders in certain testing and
laboratory services for agroscience, genomics, discovery
pharmacology and for supporting clinical studies. In addition,
Eurofins is one of the key emerging players in specialty clinical
diagnostic testing in Europe and the USA. With over 30,000 staff in
400 laboratories across 41 countries, Eurofins offers a portfolio
of over 150,000 analytical methods for evaluating the safety,
identity, composition, authenticity, origin and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group objective is to provide its
customers with high-quality services, accurate results on time and
expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgment of
Eurofins Scientific’s management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171024006272/en/
Investor RelationsEurofins ScientificPhone: +32 2 766
1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Sep 2024 to Oct 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Oct 2023 to Oct 2024